Kateřina Bouchalová

ORCID: 0000-0003-0175-7921
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Autoimmune and Inflammatory Disorders Research
  • Chronic Lymphocytic Leukemia Research
  • Cancer Treatment and Pharmacology
  • Immune Cell Function and Interaction
  • Cancer Genomics and Diagnostics
  • Systemic Lupus Erythematosus Research
  • Advanced Breast Cancer Therapies
  • Osteomyelitis and Bone Disorders Research
  • Infectious Diseases and Tuberculosis
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer, Lipids, and Metabolism
  • Orthopedic Infections and Treatments
  • Cancer Cells and Metastasis
  • Chronic Myeloid Leukemia Treatments
  • PARP inhibition in cancer therapy
  • Vitamin D Research Studies
  • Viral-associated cancers and disorders
  • Wnt/β-catenin signaling in development and cancer
  • Atherosclerosis and Cardiovascular Diseases
  • Metabolism, Diabetes, and Cancer
  • Inflammasome and immune disorders
  • DNA Repair Mechanisms
  • Pediatric Urology and Nephrology Studies

University Hospital Olomouc
2006-2025

Palacký University Olomouc
2015-2025

Weatherford College
2024

Institute of State Administration
2024

Ocní klinika
2022

Institute of Molecular and Translational Medicine
2011-2018

University Hospital Brno
2017

Hôpital René Huguenin
2010

Institut Curie
2010

Masaryk Memorial Cancer Institute
2005

Collagen triple helix repeat containing 1 (CTHRC1) affects Wnt signalling, collagen deposition and bone formation. It is an extracellular matrix protein which also abnormally expressed in the tumour microenvironment. CTHRC1 has not been studied breast cancer by immunohistochemistry.To examine expression of together with periostin versican patients investigate its association clinicopathological characteristics.The formalin-fixed paraffin-embedded tissues 173 invasive carcinomas (classified...

10.1136/jclinpath-2011-200106 article EN Journal of Clinical Pathology 2011-07-08

The publisher regrets that this article has been temporarily removed. A replacement will appear as soon possible in which the reason for removal of be specified, or reinstated. full Elsevier Policy on Article Withdrawal can found at https://www.elsevier.com/about/policies/article-withdrawal.

10.1016/j.ard.2024.11.006 article EN Annals of the Rheumatic Diseases 2025-01-01

Insulin resistance (IR) is a key and early pathogenetic mechanism of cardiometabolic diseases with huge potential if detected mitigated, for lowering the burden disease. Available data are conflicting to what extent adult thyroid dysfunction associated IR. Therefore, we aimed investigate association identify which parameters predictors IR.After undergoing basic anthropometric biochemical studies including hormones, oral glucose tolerance test (OGTT), insulin, 1425 middle-aged individuals...

10.5603/ep.a2020.0066 article EN cc-by-nc-nd Endokrynologia Polska 2020-12-30

Neither targeted therapies nor predictors for chemotherapy sensitivity are available triple-negative breast cancer (TNBC). Our study included 187 patients with TNBC, 164 of whom were treated anthracycline-based adjuvant chemotherapy. Eleven molecular biomarkers analyzed. BCL2, epidermal growth factor receptor (EGFR), MYC, TOP2A, and Ki-67 protein expression was evaluated by immunohistochemistry. The status the EGFR, TOP2A genes chromosomes 7, 8, 17 assessed using fluorescence in situ...

10.1007/s13277-015-3061-7 article EN Tumor Biology 2015-01-23

Abstract Objectives Clinical phenotyping and predicting treatment responses in SLE patients is challenging. Extensive blood transcriptional profiling has identified various gene modules that are promising for stratification of patients. We aimed to translate existing transcriptomic data into simpler signatures suitable daily clinical practice. Methods Real-time PCR multiple genes from the IFN M1.2, M5.12, neutrophil (NPh) plasma cell (PLC) modules, followed by a principle component analysis,...

10.1093/rheumatology/keac083 article EN cc-by-nc Lara D. Veeken 2022-02-03

Background: A total of 30–40% diffuse large B cell lymphoma (DLBCL) patients will either not respond to the standard therapy or their disease recur. The first-line treatment for DLBCL is rituximab and combination chemotherapy. This involves chemotherapy-induced recruitment tumor-associated macrophages that recognize kill rituximab-opsonized cells. However, we lack insights into factors responsible functionality in tumors. Methods: We have studied effects immunomodulatory lipid...

10.3390/cancers16030574 article EN Cancers 2024-01-29

Eligibility to anti‐HER2 therapy for breast tumors strictly depends on demonstrating HER2 overexpression (by immunohistochemistry) or gene amplification by in situ hybridization (ISH), usually defined the ratio of chromosome 17 centromere (CEP17) copies. However, CEP17 copy number increase (CNI) has been proven responsible misleading FISH results and recent small cohort studies suggest that polysomy is actually very rare. Here we investigated frequency true a consecutive 5,477 invasive...

10.1002/gcc.22337 article EN Genes Chromosomes and Cancer 2016-02-05

Individuals with congenital solitary functioning kidney (SFK) are at an increased risk of damage. According to some studies, the is higher in unilateral agenesis (UKA) than multicystic dysplastic (UMCDK). We hypothesized that early detection children UKA and UMCDK, there would be no difference presence hypertension, proteinuria, reduced glomerular filtration rate (GFR) between UMCDK.

10.1007/s00467-024-06360-2 article EN cc-by Pediatric Nephrology 2024-04-15

We report here a case of newborn with hypotrophy and somatic stigmatization: microcephaly, facial dysmorphism, heart defect immunodeficiency syndrome. The proband's karyotype was 46,XY,dup(4)(q28q35.2) de novo chromosomal breaks in 4% metaphases. demonstrate the usefulness combination physical examination, classical cytogenetics, FISH PCR techniques order to establish correct diagnosis because overlap some clinical cytogenetic features Nijmegen breakage syndrome (NBS) duplication 4q our...

10.5507/bp.2006.016 article EN cc-by Biomedical Papers 2006-07-01

With an increasing number of cancer patients receiving tyrosine kinase inhibitors (TKIs), therapeutic drug monitoring these molecules is becoming more widespread today. It mainly based on liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) methods typical run times several minutes. In online solid phase extraction-MS/MS (SPE-MS/MS) system, the column replaced a reusable extraction (SPE) cartridge and analysis time shortened to less than half minute. The aim this study was...

10.1097/ftd.0000000000000309 article EN Therapeutic Drug Monitoring 2016-07-14

Lapatinib is a tyrosine kinase inhibitor targeting epidermal growth factor receptors 1 (EGFR/HER1) and 2 (HER2) used in the treatment of patients with HER2-positive breast cancer. The aim present study was to determine lapatinib plasma levels cancer treated plus capecitabine.We assessed blood samples from 21 capecitabine using standard regimen an expanded access program. Liquid chromatography tandem mass spectrometry for measuring concentrations. validated method applied measurement 55...

10.1177/030089161209800123 article EN Tumori Journal 2012-01-01

Lapatinib is a tyrosine kinase inhibitor targeting epidermal growth factor receptors 1 (EGFR/HER1) and 2 (HER2) used in the treatment of patients with HER2-positive breast cancer. The aim present study was to determine lapatinib plasma levels cancer treated plus capecitabine.We assessed blood samples from 21 capecitabine using standard regimen an expanded access program. Liquid chromatography tandem mass spectrometry for measuring concentrations. validated method applied measurement 55...

10.1700/1053.11516 article EN Tumori Journal 2012-04-13

1087 Background: Preclinical data show an association of BCL2 expression and resistance to anthracyclines. The absence in prechemotherapy samples is associated with a higher probability pathological complete response neoadjuvant doxorubicin-based chemotherapy. aim our research identification markers predicting sensitivity adjuvant treatment TNBC. Here we focus on protein as putative predictor anthracycline-based objective was determine whether predicts relapse TNBC patients treated regimens....

10.1200/jco.2012.30.15_suppl.1087 article EN Journal of Clinical Oncology 2012-05-20

Juvenile primary Sjögren syndrome (pSS) with renal involvement is extremely rare, reported approximately in 50 children, predominantly girls. Here, we present the first case of a male child juvenile pSS ocular surface disease (previously keratoconjunctivitis sicca), submandibular salivary gland involvement, and tubulointerstitial nephritis. First, two symptoms were clinically apparent at presentation. We illustrate here that kidney should be actively looked for, as may associated...

10.3390/diagnostics14030258 article EN cc-by Diagnostics 2024-01-25
Coming Soon ...